(2020). Risk of developing checkpoint immune pneumonitis and its effect on overall survival in non-small cell lung cancer patients previously treated with radiotherapy.
Chicago Style (17th ed.) CitationRisk of Developing Checkpoint Immune Pneumonitis and Its Effect on Overall Survival in Non-small Cell Lung Cancer Patients Previously Treated with Radiotherapy. 2020.
MLA (8th ed.) CitationRisk of Developing Checkpoint Immune Pneumonitis and Its Effect on Overall Survival in Non-small Cell Lung Cancer Patients Previously Treated with Radiotherapy. 2020.
Warning: These citations may not always be 100% accurate.